Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

15 projects found matching your search criteria :

  1. Identification of cytochrome P450 isoenzymes involved in the metabolism of levomepromazine in the human

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii PAN

  2. The effect of typical and atypical neuroleptics on the expression of cytochrome P450 isoenzymes 1A2 (CYP1A2) and 3A4 (CY...

    Call: PRELUDIUM 8 , Panel: NZ7

    Principal investigator: Agnieszka Basińska-Ziobroń

    Instytut Farmakologii PAN

  3. Changes in the proteome of the filamentous fungus Cunninghamella echinulata during degradation of organic tin compounds

    Call: PRELUDIUM 7 , Panel: NZ9

    Principal investigator: Adrian Soboń

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  4. The effect of the novel atypical neuroleptics on the activity and expression of cytochrome P450 isoforms in human liver

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii PAN

  5. The significance of the serotonergic innervation of the brain hypothalamus in the regulation of cytochrome P450

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: prof. Władysława Daniel

    Instytut Farmakologii PAN

  6. Influence of chlorpyrifos on the activity of enzymes responsible for the vitamin D3 synthesis in skin cells

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: Krzysztof Sawicki

    Instytut Medycyny Wsi im. Witolda Chodźki

  7. The role of the brain serotonergic system in the expression and activity of liver cytochrome P450.

    Call: PRELUDIUM 4 , Panel: NZ7

    Principal investigator: dr Marta Rysz

    Instytut Farmakologii, Polska Akademia Nauk

  8. Studies on the mechanism regulating expression of hormone-dependent cytochromes P450 in the rat liver under conditions o...

    Call: PRELUDIUM 4 , Panel: NZ4

    Principal investigator: Rafał Skowronek

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Lekarski w Katowicach

  9. The influence of the serotonergic system on the regulation of liver CYP activity in hepatocellular carcinoma

    Call: SONATA 4 , Panel: NZ4

    Principal investigator: dr Marta Kot

    Instytut Farmakologii PAN

  10. Evaluation of the synthesis and metabolism modulation of estrogens - breast cancer risk factors by new synthetic resvera...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: prof. Wanda Baer-Dubowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  11. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Władysława Daniel

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  12. The effect of chronic treatment with iasenapine and iloperidone on the expression and activity of cytochrome P450 in the...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Przemysław Danek

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  13. The role of brain glutamatergic system in the neuroendocrine regulation of cytochrome P450 expression and activity in th...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Władysława Daniel

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  14. Mechanism of interaction between carbon nanoparticles of diamond, graphene oxide and graphite and cytochrome P450 enzyme...

    Call: PRELUDIUM 11 , Panel: NZ7

    Principal investigator: Barbara Strojny

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Nauk o Zwierzętach

  15. Porphyrazine based catalyst support for biomimetic studies on selected active pharmaceutical ingredients

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: Tomasz Koczorowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny